Mineralys Therapeutics, Inc. (MLYS)

MLYS is a sell reflecting weak short-term momentum, distributionary volume and elevated volatility relative to the price. The security trades below its short-, medium- and long-term moving averages, MACD and momentum readings are negative, and RSI is near the lower range, while stochastic measures hint at oversold conditions without confirming strength. ADX is low, indicating the trend lacks force, yet on-balance volume shows persistent outflows. ATR is relatively high versus the share price, underscoring larger swings amid the downtrend and the pivot sits above current levels. Technical takeaway: Sell — below major moving averages with negative momentum and weak volume.